Informations générales (source: ClinicalTrials.gov)

NCT03111693 Statut inconnu
CT Evaluation of Cardiovascular Risk Markers in Obese Patients (RisqOScan)
Observational
  • Syndrome métabolique X
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
novembre 2014
décembre 2017
29 juin 2024
Obesity is a chronic metabolic disorder : it leads to coronary heart disease and early atherosclerosis. Coronary artery calcium measured by CT is known as a robust predictor to predict risk for cardiac events in symptomatic and asymptomatic individuals. Furthermore, recent studies show that other CT risk factor exists, independent of calcium scoring, such as epicardial fat, intrathoracic fat and visceral fat. The aim of this prospective study is to evaluate these new cardiovascular risk markers in obese patients, using standard dose CT and low dose CT with adaptative statistical iterative reconstruction.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHU Clermont-Ferrand - 63003 - Clermont-Ferrand - France Patrick LACARIN En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- obesity >30 indicated non enhanced coroCT for calcium scoring.



- <18 ans

- low Framingham scoring

- pregnancy

- not providing informed consent

- history of cardiovascular disease.